Kevin Young
2008
In 2008, Kevin Young earned a total compensation of $4.1M as Executive Vice President, Commercial Operations at Gilead Sciences, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $440,160 |
|---|---|
| Option Awards | $2,182,460 |
| Salary | $557,505 |
| Stock Awards | $877,455 |
| Other | $13,318 |
| Total | $4,070,898 |
Young received $2.2M in option awards, accounting for 54% of the total pay in 2008.
Young also received $440.2K in non-equity incentive plan, $557.5K in salary, $877.5K in stock awards and $13.3K in other compensation.
Rankings
In 2008, Kevin Young's compensation ranked 1,117th out of 9,135 executives tracked by ExecPay. In other words, Young earned more than 87.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,117 out of 9,135 | 88th |
Division Manufacturing | 406 out of 3,436 | 88th |
Major group Chemicals And Allied Products | 78 out of 815 | 90th |
Industry group Drugs | 49 out of 597 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 8 out of 118 | 93rd |
Source: SEC filing on March 22, 2011.
Young's colleagues
We found six more compensation records of executives who worked with Kevin Young at Gilead Sciences in 2008.
2008
John Martin
Gilead Sciences
Chief Executive Officer
2008
John Milligan
Gilead Sciences
Chief Operating Officer
2008
Norbert Bischofberger
Gilead Sciences
Chief Scientific Officer
2008
Robin Washington
Gilead Sciences
Chief Financial Officer
2008
Gregg Alton
Gilead Sciences
Executive Vice President, Corporate and Medical Affairs
2008
Caroline Dorsa
Gilead Sciences